Switzerland· 39220001
Tiapridal, Tabletten
A tiapride product, registered in Switzerland by Neuraxpharm Switzerland AG and dispensed under Swissmedic category B. The same ATC class is registered in 7 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Tiapride is registered in 7 of 19 countries.
Countries holding a registration under ATC N05AL03 (tiapride), each read from that country’s own register.
- This record: Switzerland
- 6 of them publish a price we can compare per daily dose
Tiapride · ATC N05AL03
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Franceprice
- Germany
- Italyprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of tiapride costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- Switzerland: $2.18 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Tiapride · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.18
The record
At a glance
- Manufacturer
- Neuraxpharm Switzerland AG
- Country
- Switzerland (CH)
- ATC code
- N05AL03
- ATC class
- Tiapride
- Defined daily dose
- 0.4 g, O
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for tiapride.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tiapride · interactions on record
5 records
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under N05AL03
Tiapride, as other registers publish it.
- ItalySEREPRILE*10 fiale IM EV 100 mg 2 mlNEURAXPHARM ITALY SpA
- CzechiaTIAPRAZentiva, k.s., Praha
- CzechiaTIAPRAZentiva, k.s., Praha
- CzechiaTIAPRAZentiva, k.s., Praha
- CzechiaTIAPRALANG.L. Pharma GmbH, Lannach
- CzechiaTIAPRALANG.L. Pharma GmbH, Lannach
- CzechiaTIAPRALANG.L. Pharma GmbH, Lannach
- CzechiaTIAPRALANG.L. Pharma GmbH, Lannach
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/61358675-7ddb-4093-bcc4-c8180495c1a2 GET /v1/drugs/61358675-7ddb-4093-bcc4-c8180495c1a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about tiapride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.